Rozen Le Panse Selected Research

Myasthenia Gravis

1/2022	Myasthenia Gravis: An Acquired Interferonopathy?
10/2020	Decreased expression of miR-29 family associated with autoimmune myasthenia gravis.
1/2020	Comparative Analysis of Thymic and Blood Treg in Myasthenia Gravis: Thymic Epithelial Cells Contribute to Thymic Immunoregulatory Defects.
1/2020	Role of miRNAs in Normal and Myasthenia Gravis Thymus.
1/2019	Il-23/Th17 cell pathway: A promising target to alleviate thymic inflammation maintenance in myasthenia gravis.
1/2019	Causes and Consequences of miR-150-5p Dysregulation in Myasthenia Gravis.
1/2019	The Muscle Is Not a Passive Target in Myasthenia Gravis.
1/2019	Thymectomy in myasthenia gravis: when, why, and how?
11/2018	Regulatory B cells in myasthenia gravis are differentially affected by therapies.
6/2018	Analysis of microRNA expression in the thymus of Myasthenia Gravis patients opens new research avenues.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Rozen Le Panse Research Topics

Disease

39	Myasthenia Gravis 01/2022 - 05/2005
19	Autoimmune Diseases (Autoimmune Disease) 01/2022 - 12/2006
8	Thymus Hyperplasia 01/2018 - 12/2006
7	Neuromuscular Diseases (Neuromuscular Disease) 01/2019 - 10/2009
6	Inflammation (Inflammations) 01/2020 - 05/2007
5	Thymoma (Thymic Carcinoma) 01/2022 - 08/2014
5	Hyperplasia 10/2020 - 12/2006
4	Muscle Weakness 01/2020 - 08/2014
4	Virus Diseases (Viral Diseases) 01/2017 - 07/2013
1	Intellectual Disability (Idiocy) 11/2021
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2018
1	Congenital Structural Myopathies (Centronuclear Myopathy) 11/2017
1	Papillomavirus Infections 08/2014

Drug/Important Bio-Agent (IBA)

26	Cholinergic ReceptorsIBA 01/2022 - 05/2005
24	AntibodiesIBA 01/2022 - 05/2007
14	AutoantibodiesIBA 10/2020 - 12/2006
5	MicroRNAs (MicroRNA)IBA 01/2020 - 10/2013
3	Interferon Type IIBA 01/2022 - 08/2014
3	Biological ProductsIBA 01/2020 - 08/2014
3	Interleukin-17 (Interleukin 17)IBA 01/2019 - 12/2012
3	Proteins (Proteins, Gene)FDA Link 01/2019 - 08/2014
3	ChemokinesIBA 01/2018 - 08/2014
3	CytokinesIBA 01/2018 - 05/2005
3	Double-Stranded RNA (RNA, Double Stranded)IBA 01/2017 - 02/2013
2	Adrenal Cortex Hormones (Corticosteroids)IBA 11/2018 - 02/2017
2	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 01/2018 - 01/2014
2	InterferonsIBA 01/2018 - 02/2017
2	Toll-Like Receptors (Toll-Like Receptor)IBA 02/2017 - 07/2013
2	Estrogens (Estrogen)FDA Link 02/2017 - 04/2016
2	DNA (Deoxyribonucleic Acid)IBA 08/2014 - 09/2008
2	Phosphotransferases (Kinase)IBA 10/2013 - 10/2011
1	5' Untranslated Regions (5' UTR)IBA 11/2021
1	Messenger RNA (mRNA)IBA 01/2020
1	Acetylcholine (Acetylcholine Chloride)FDA Link 01/2020
1	Interleukin-23 (Interleukin 23)IBA 01/2019
1	AutoantigensIBA 01/2018
1	Monoclonal AntibodiesIBA 01/2018
1	Humanized Monoclonal AntibodiesIBA 01/2018
1	Interleukin-6 (Interleukin 6)IBA 01/2018
1	Interleukin-12 (IL 12)IBA 01/2018
1	Surface Antigens (Surface Antigen)IBA 01/2018
1	Choline (Choline Chloride)IBA 12/2017
1	myotubularinIBA 11/2017
1	MyostatinIBA 11/2017
1	AntigensIBA 02/2017
1	Poly I-CIBA 01/2017
1	Toll-Like Receptor AgonistsIBA 01/2017
1	Neutralizing AntibodiesIBA 08/2014
1	Toll-Like Receptor 3IBA 08/2014
1	Protein Kinases (Protein Kinase)IBA 08/2014
1	Interferon-betaIBA 08/2014
1	Biomarkers (Surrogate Marker)IBA 01/2014
1	myasthenia gravis anti-skeletal muscle antibody (ASMA)IBA 10/2013
1	Complement System Proteins (Complement)IBA 10/2013
1	ErbB Receptors (EGF Receptor)IBA 03/2011
1	muskIBA 03/2011
1	Cholinergic Agents (Cholinergics)IBA 05/2007
1	AcetylcholinesteraseIBA 05/2007
1	LigandsIBA 12/2006
1	CC ChemokinesIBA 12/2006

Therapy/Procedure

5	Thymectomy 01/2019 - 12/2006
4	Therapeutics 11/2018 - 05/2007
1	Injections 01/2017
1	Cell- and Tissue-Based Therapy (Cell Therapy) 07/2013